Skip to main content

Table 1 Clinicopathologic characteristics of patientes

From: HER2 overexpression and correlation with other significant clinicopathologic parameters in Ivorian breast cancer women

Variables

Number of patients N (%)

Age (years)

 Mean ± SD

47.9 ± 11

 Extremes

24–90

Menopausal status

 Premenopause

355 (58.4)

 Postmenopause

253 (41.6)

Histologic type

 IDC-NST

511(84.1)

 Lobular

30 (4.9)

 Other

67 (11)

Nottingham grade

 I

100 (19.5)

 II

307 (59.8)

 III

106 (20.7)

 Indetermined

95 (00)

ER

 Positive

334 (54.9)

 Negative

274 (45.1)

PR

 Positive

252 (41.5)

 Negative

356 (58.5)

HER2

 Positive

105 (17.3)

 Negative

472 (77.6)

 Equivocal

31(5.1)

ER/PR

 ER/PR+

356 (58.5)

 ER/PR-

252 (41.5)

Molecular subtype

 Luminal A

268 (46.4)

 Luminal B

68 (11.8)

 HER2 enriched

37 (6.4)

 Triple negative

204 (35.4)

  1. ER Estrogen receptor, HER2 Human epidermal growth factor receptor 2, IDC-NST Invasive ductal carcinoma of no special type, PR Progesterone receptor, SD Standard deviation